上海医药
上海醫藥
상해의약
SHANGHAI MEDICAL & PHARMACEUTICAL JOURNAL
2014年
12期
3-5,9
,共4页
李登峰%魏传奎%宋洪明%李晓宇%罗颀枫%陈磊%黄毅祥%菅伟%房林
李登峰%魏傳奎%宋洪明%李曉宇%囉頎楓%陳磊%黃毅祥%菅偉%房林
리등봉%위전규%송홍명%리효우%라기풍%진뢰%황의상%관위%방림
乳腺肿瘤%圆柱瘤基因%miR-130a-3p%MCF-7细胞
乳腺腫瘤%圓柱瘤基因%miR-130a-3p%MCF-7細胞
유선종류%원주류기인%miR-130a-3p%MCF-7세포
breast neoplasms%cylindromatosis%mir-130a-3p%MCF-7 cell
目的:探讨miR-130a-3p对人乳腺癌MCF-7细胞功能的影响及其可能的靶向基因。方法:应用脂质体介导方法将miR-130a-3p模拟物(实验组)或对照模拟物(对照组)转染MCF-7细胞,分别采用MTT方法和细胞划痕实验检测细胞增殖和迁移能力变化,印迹法检测细胞中miR-130a-3p靶基因圆柱瘤基因(CYLD)的表达。结果:与对照组比较,实验组MCF-7细胞的增殖和迁移能力增强(P<0.05),细胞中CYLD蛋白表达水平明显下调(P<0.05)。结论:miR-130a-3p可能通过靶向调节CYLD蛋白表达增强人乳腺癌MCF-7细胞的增殖和迁移。
目的:探討miR-130a-3p對人乳腺癌MCF-7細胞功能的影響及其可能的靶嚮基因。方法:應用脂質體介導方法將miR-130a-3p模擬物(實驗組)或對照模擬物(對照組)轉染MCF-7細胞,分彆採用MTT方法和細胞劃痕實驗檢測細胞增殖和遷移能力變化,印跡法檢測細胞中miR-130a-3p靶基因圓柱瘤基因(CYLD)的錶達。結果:與對照組比較,實驗組MCF-7細胞的增殖和遷移能力增彊(P<0.05),細胞中CYLD蛋白錶達水平明顯下調(P<0.05)。結論:miR-130a-3p可能通過靶嚮調節CYLD蛋白錶達增彊人乳腺癌MCF-7細胞的增殖和遷移。
목적:탐토miR-130a-3p대인유선암MCF-7세포공능적영향급기가능적파향기인。방법:응용지질체개도방법장miR-130a-3p모의물(실험조)혹대조모의물(대조조)전염MCF-7세포,분별채용MTT방법화세포화흔실험검측세포증식화천이능력변화,인적법검측세포중miR-130a-3p파기인원주류기인(CYLD)적표체。결과:여대조조비교,실험조MCF-7세포적증식화천이능력증강(P<0.05),세포중CYLD단백표체수평명현하조(P<0.05)。결론:miR-130a-3p가능통과파향조절CYLD단백표체증강인유선암MCF-7세포적증식화천이。
Objective:To investigate the effect of miR-130a-3p on the function of human breast cancer cell line MCF-7, and to explore its possible target gene. Methods: miR-130a-3p mimics or its negative control (miR-130a-3p mimics-NC) was transfected into MCF-7 cells by lipofectamine. The capacities of proliferation and migration of MCF-7 cells were evaluated by MTT and Scratch assay, respectively. The expression of CYLD which was predicted as a target gene in MCF-7 cells was determined by Western blotting. Results:The capacities of proliferation and migration in MCF-7 cells transfected with miR-130a-3p mimics were signiifcantly promoted and the expression level of CYLD was down-regulated when compared with those in MCF-7 cells transfected with miR-130a-3p mimics-NC(P<0.05). Conclusion:The miR-130a-3p expression can promote the proliferation and migration of human breast cancer line MCF-7 by down-regulating the expression of CYLD.